
    
      Safety: Treatment-Emergent Adverse Events (AE); Treatment related AE, Serious Adverse Events
      (SAE) and Clinical significant AE; Dose Limiting Toxicities (DLT).

      Pharmacokinetics (PK): Peak Plasma Concentration (Cmax), Area under the plasma concentration
      versus time curve (AUC), Time of Maximum Concentration Observed (Tmax).

      Efficacy: Overall Response Rate (ORR), Progression Free Survival (PFS); Overall Survival (OS)
      and duration of Response (DoR).
    
  